Could a single, smarter surgery spare bladder cancer patients a second operation?

NCT ID NCT05962541

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two approaches for treating non-muscle invasive bladder cancer. The standard approach uses two surgeries: one to remove the tumor and a second to check for leftover cancer. The new approach uses a single, enhanced surgery with a special dye and light to better see and remove all cancer at once. The goal is to see if the single surgery is as safe and effective as the two-step method, potentially saving patients from an extra procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy

    RECRUITING

    Rome, Lazio, 00161, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.